These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9148379)

  • 1. Type II diabetic nephropathy: its clinical course and therapeutic implications.
    Rodby RA
    Semin Nephrol; 1997 Mar; 17(2):132-47. PubMed ID: 9148379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of angiotensin II AT1-receptor antagonists in renal and cardiac protection in type-2 diabetes mellitus].
    Ravera M; Deferrari L; Ratto E; Vettoretti S; Parodi D; Deferrari G
    Ital Heart J Suppl; 2003 Mar; 4(3):210-6. PubMed ID: 12784755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Losartan in diabetic nephropathy.
    Perico N; Ruggenenti P; Remuzzi G
    Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):473-83. PubMed ID: 15225108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertension and renal complications in type 2 diabetes.
    Nosadini R
    Semin Vasc Med; 2002 Feb; 2(1):109-19. PubMed ID: 16222601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diabetic nephropathy. A historical, clinical and diagnostic framework].
    Conti AA
    Minerva Med; 2002 Oct; 93(5):347-55. PubMed ID: 12410167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Guidelines for diagnosis and therapy of diabetic nephropathy].
    De Ferrari G;
    G Ital Nefrol; 2003; 20 Suppl 24():S96-108. PubMed ID: 14666506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Albuminuria: a target for treatment of type 2 diabetic nephropathy.
    de Zeeuw D
    Semin Nephrol; 2007 Mar; 27(2):172-81. PubMed ID: 17418686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of nephropathy in patients with type 2 diabetes.
    Critchley JA; Zhao HL; Tomlinson B; Leung W; Thomas GN; Chan JC; Cockram CS
    Chin Med J (Engl); 2002 Jan; 115(1):129-35. PubMed ID: 11930647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic interventions for nephropathy in type I diabetes mellitus.
    Breyer JA
    Semin Nephrol; 1997 Mar; 17(2):114-23. PubMed ID: 9148377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Type 2 diabetes and nephropathy--new studies, new treatment strategies?].
    Os I; Stenehjem A; Høieggen A; Draganov B; Jenssen T; Holdaas H
    Tidsskr Nor Laegeforen; 2002 Apr; 122(9):918-20. PubMed ID: 12082835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers for prevention and treatment of nephropathy associated with type 2 diabetes mellitus.
    Hughes DB; Britton ML
    Pharmacotherapy; 2005 Nov; 25(11):1602-20. PubMed ID: 16232022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of losartan on renal and cardiovascular complications of patients with type 2 diabetes and nephropathy].
    Parving HH; Brenner BM; Cooper ME; de Zeeuw D; Keane WF; Mitch WE; Remuzzi G; Snapinn SM; Zhang Z; Shahinfar S
    Ugeskr Laeger; 2001 Oct; 163(40):5514-9. PubMed ID: 11601117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diabetes mellitus, hypertension and kidney].
    Monhart V
    Vnitr Lek; 2008 May; 54(5):499-504, 507. PubMed ID: 18630636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic controversies in hypertension management: angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers for diabetic nephropathy? A case for ACE inhibitors.
    Crook ED; Preddie DC
    Ethn Dis; 2002; 12(4):S3-49-52. PubMed ID: 12477155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L; Kocks MJ; Laverman GD; Navis G
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening and management of patients with early chronic kidney disease.
    Rossert J; Fouqueray B
    Acta Diabetol; 2004 Mar; 41 Suppl 1():S6-12. PubMed ID: 15103542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetic nephropathy. Prevention and early referral.
    Pylypchuk G; Beaubien E
    Can Fam Physician; 2000 Mar; 46():636-42. PubMed ID: 10752002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy with angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists in the treatment of patients with type 2 diabetes mellitus.
    Rosner MH; Okusa MD
    Arch Intern Med; 2003 May; 163(9):1025-9. PubMed ID: 12742799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of diabetic nephropathy in its early stages.
    Deferrari G; Ravera M; Berruti V
    Diabetes Metab Res Rev; 2003; 19(2):101-14. PubMed ID: 12673778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Improved prognosis of Type I and Type II diabetics with nephropathy].
    Hasslacher C; Borgholte G; Panradl U; Wahl P
    Med Klin (Munich); 1990 Nov; 85(11):643-6. PubMed ID: 2266913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.